Hasan Bhally

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone Resistance

Patrick N. A. Harris, Paul Anantharajah Tambyah, David Chien Lye et al. · JAMA · 2018 · 770 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study

Andrew Henderson, David L. Paterson, Mark D. Chatfield et al. · Clinical Infectious Diseases · 2020 · 158 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Utility of Extended Blood Culture Incubation for Isolation of <i>Haemophilus, Actinobacillus, Cardiobacterium, Eikenella</i> , and <i>Kingella</i> Organisms: a Retrospective Multicenter Evaluation

Cathy A. Petti, Hasan Bhally, Melvin P. Weinstein et al. · Journal of Clinical Microbiology · 2006 · 126 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

Evaluation of the BD Phoenix Automated Microbiology System for Identification and Antimicrobial Susceptibility Testing of <i>Enterobacteriaceae</i>

Karen C. Carroll, Brian Glanz, Anita P. Borek et al. · Journal of Clinical Microbiology · 2006 · 86 citations · Full text

Life Sciences, Microbiology, Bacteriology +16

Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27

Patrick N. A. Harris, Nouri L. Ben Zakour, Leah W. Roberts et al. · Journal of Antimicrobial Chemotherapy · 2017 · 82 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17